Costs and outcomes evaluation of patient navigation after abnormal cancer screening: Evidence from the Patient Navigation Research Program

BACKGROUND Navigators can facilitate timely access to cancer services, but to the authors' knowledge there are little data available regarding their economic impact. METHODS The authors conducted a cost‐consequence analysis of navigation versus usual care among 10,521 individuals with abnormal...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 2014-02, Vol.120 (4), p.570-578
Main Authors: Bensink, Mark E., Ramsey, Scott D., Battaglia, Tracy, Fiscella, Kevin, Hurd, Thelma C., McKoy, June M., Patierno, Steven R., Raich, Peter C., Seiber, Eric E., Warren‐Mears, Victoria, Whitley, Elizabeth, Paskett, Electra D., Mandelblatt, S.
Format: Article
Language:English
Subjects:
abnormal cancer screening
Biological and medical sciences
cancer
cost
Cost-Benefit Analysis - economics
Early Detection of Cancer
Female
Healthcare Disparities
Humans
Male
Mass Screening
Medical sciences
Minority Groups
Multiple tumors. Solid tumors. Tumors in childhood (general aspects)
navigation
Neoplasms - diagnosis
Neoplasms - economics
Neoplasms - epidemiology
Neoplasms - pathology
outcomes
Time Factors
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND Navigators can facilitate timely access to cancer services, but to the authors' knowledge there are little data available regarding their economic impact. METHODS The authors conducted a cost‐consequence analysis of navigation versus usual care among 10,521 individuals with abnormal breast, cervical, colorectal, or prostate cancer screening results who enrolled in the Patient Navigation Research Program study from January 1, 2006 to March 31, 2010. Navigation costs included diagnostic evaluation, patient and staff time, materials, and overhead. Consequences or outcomes were time to diagnostic resolution and probability of resolution. Differences in costs and outcomes were evaluated using multilevel, mixed‐effects regression modeling adjusting for age, race/ethnicity, language, marital status, insurance status, cancer, and site clustering. RESULTS The majority of individuals were members of a minority (70.7%) and uninsured or publically insured (72.7%). Diagnostic resolution was higher for navigation versus usual care at 180 days (56.2% vs 53.8%; P = .008) and 270 days (70.0% vs 68.2%; P 
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.28438